ConductScience.org, home

Paper36901797

Aducanumab-Hope or Disappointment for Alzheimer's Disease.

Wojtunik-Kulesza K and 2 others. Int J Mol Sci, 2023. Cited by 55 papers, by iCite.

Cite this record

ConductScience Library. Aducanumab-Hope or Disappointment for Alzheimer's Disease. Papers, record 36901797. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36901797

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Aducanumab-Hope or Disappointment for Alzheimer's Disease.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
6.38
iCite
Revised in PubMed
2023-03-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wojtunik-Kulesza KKarolinahttps://orcid.org/0000-0002-6541-8817
2Rudkowska MMonika
3Orzeł-Sajdłowska AAnna

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Humans
Amyloid beta-Peptides
Antibodies, Monoclonal, Humanized
Emotions
Immunoglobulin G

References82

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127582220The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.Nature2016https://conductscience.org/library/papers/27582220PubMed
236142659Regulation of the Soluble Amyloid Precursor Protein α (sAPPα) Levels by Acetylcholinesterase and Brain-Derived Neurotrophic Factor in Lung Cancer Cell Media.Int J Mol Sci2022https://conductscience.org/library/papers/36142659PubMed
38894693cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein.Hum Mol Genet1996https://conductscience.org/library/papers/8894693PubMed
430011822Precision Medicine for Alzheimer's Disease Prevention.Healthcare (Basel)2018https://conductscience.org/library/papers/30011822PubMed
527048170Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody.Alzheimers Res Ther2016https://conductscience.org/library/papers/27048170PubMed
632941929Alzheimer's disease: Recent treatment strategies.Eur J Pharmacol2020https://conductscience.org/library/papers/32941929PubMed
722920732Monoclonal antibody therapeutics: history and future.Curr Opin Pharmacol2012https://conductscience.org/library/papers/22920732PubMed
830938796Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.JAMA2019https://conductscience.org/library/papers/30938796PubMed
927810931Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.J Neurosci2016https://conductscience.org/library/papers/27810931PubMed
1033319314A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.Acta Neuropathol2021https://conductscience.org/library/papers/33319314PubMed
1128691573Plasticity in the Working Memory System: Life Span Changes and Response to Injury.Neuroscientist2018https://conductscience.org/library/papers/28691573PubMed
1220813343Alzheimer's disease, a multifactorial disorder seeking multitherapies.Alzheimers Dement2010https://conductscience.org/library/papers/20813343PubMed
1330787102In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease.J Biol Chem2019https://conductscience.org/library/papers/30787102PubMed
1421257651Brain microbleeds and Alzheimer's disease: innocent observation or key player?Brain2011https://conductscience.org/library/papers/21257651PubMed
1518056160Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.Brain2008https://conductscience.org/library/papers/18056160PubMed
161172191Continuous cultures of fused cells secreting antibody of predefined specificity.Nature1975https://conductscience.org/library/papers/1172191PubMed
1723703910Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23703910PubMed
1822487856Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.J Neuropathol Exp Neurol2012https://conductscience.org/library/papers/22487856PubMed
1929686315Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.Sci Rep2018https://conductscience.org/library/papers/29686315PubMed
2034595939Accelerated Approval of Aducanumab: Where Do We Stand Now?Ann Pharmacother2022https://conductscience.org/library/papers/34595939PubMed

See all 82 referencesDownload CSV of references

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
42389265Advances in the treatment of Alzheimer's disease.Front Pharmacol2026https://conductscience.org/library/papers/42389265PubMed
42286894A mechanistic framework linking the oral microbiome to Alzheimer's disease through neuroinflammation.J Alzheimers Dis2026https://conductscience.org/library/papers/42286894PubMed
42277828Meningeal lymphatic dysfunction in Alzheimer's disease: molecular mechanisms, clinical implications, and future perspectives.Mol Neurodegener2026https://conductscience.org/library/papers/42277828PubMed
42229063Friend or foe? Glial-vascular interactions in health and neurodegenerative disease.Pharmacol Rev2026https://conductscience.org/library/papers/42229063PubMed
42038337Cynanchum bungei Decne-derived extracellular vesicles alleviate cognitive impairment and pathological damage in Alzheimer's disease.Front Cell Neurosci2026https://conductscience.org/library/papers/42038337PubMed
42038088Depression as an early symptom and risk factor of dementia - a narrative review.Front Psychiatry2026https://conductscience.org/library/papers/42038088PubMed
41870777Bridging the gaps in alzheimer's disease: a comprehensive review of current and emerging therapies.Inflammopharmacology2026https://conductscience.org/library/papers/41870777PubMed
41760646Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins.Nat Commun2026https://conductscience.org/library/papers/41760646PubMed
40914973Integrative physiology of skeletal muscle for maintaining cognitive health.J Physiol2026https://conductscience.org/library/papers/40914973PubMed
40806679The Therapeutic Potential of Glymphatic System Activity to Reduce the Pathogenic Accumulation of Cytotoxic Proteins in Alzheimer's Disease.Int J Mol Sci2025https://conductscience.org/library/papers/40806679PubMed
40546798Potential Applications of Natural Components of Traditional Chinese Medicine Delivery via Nanoparticle Drug Delivery Systems in the Treatment of Alzheimer's Disease.Int J Nanomedicine2025https://conductscience.org/library/papers/40546798PubMed
40507988The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.Int J Mol Sci2025https://conductscience.org/library/papers/40507988PubMed
40503182Tracing the aggregation pathway of the scaffold protein DISC1: Structural implications for chronic mental illnesses.J Struct Biol X2025https://conductscience.org/library/papers/40503182PubMed
40429735N-N-Substituted Piperazine, Cmp2, Improves Cognitive and Motor Functions in 5xFAD Mice.Int J Mol Sci2025https://conductscience.org/library/papers/40429735PubMed
40095208Intranasal Delivery of Lithium Salt Suppresses Inflammatory Pyroptosis in the Brain and Ameliorates Memory Loss and Depression-like Behavior in 5XFAD Mice.J Neuroimmune Pharmacol2025https://conductscience.org/library/papers/40095208PubMed
40002308Inflammasomes in Alzheimer's Progression: Nrf2 as a Preventive Target.Antioxidants (Basel)2025https://conductscience.org/library/papers/40002308PubMed
39962970Inhibitors of soluble epoxide hydrolase and cGAS/STING repair defects in amyloid-β clearance underlying vascular complications of Alzheimer's disease.J Alzheimers Dis2025https://conductscience.org/library/papers/39962970PubMed
39926227Nanoscale drug formulations for the treatment of Alzheimer's disease progression.RSC Adv2025https://conductscience.org/library/papers/39926227PubMed
39806952Design, Synthesis, Biological Evaluation and Docking Studies of 2-hydroxy-4-benzyloxy Chalcone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease.Curr Med Chem2026https://conductscience.org/library/papers/39806952PubMed
39559726Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals.Beilstein J Nanotechnol2024https://conductscience.org/library/papers/39559726PubMed

See all 37 cited byDownload CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36901797

GET https://conductscience.org/api/papers/v1/36901797/references?page=2